Stay updated on BIVV009 Safety & Activity in Complement Disorders Clinical Trial
Sign up to get notified when there's something new on the BIVV009 Safety & Activity in Complement Disorders Clinical Trial page.

Latest updates to the BIVV009 Safety & Activity in Complement Disorders Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check39 days agoChange DetectedThe web page has undergone significant updates, including the renaming of the study drug from TNT009 to BIVV009 and the addition of a new study part focused on patients with cold agglutinin disease. Additionally, the revision number has been updated to v2.15.0.SummaryDifference50%
- Check46 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check53 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check82 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check103 days agoChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
Stay in the know with updates to BIVV009 Safety & Activity in Complement Disorders Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BIVV009 Safety & Activity in Complement Disorders Clinical Trial page.